Variables | Study group | t | p-value | CI | ||
Tranexamic Acid Mean ± SD | Placebo Mean ± SD | Lower | Upper | |||
Baseline clinical characteristics |
|
|
|
|
| |
Systolic BP (mmHg) | 124.76 ± 9.64 | 119.83 ± 22.53 | 1.695 | 0.092 | −0.821 | 10.680 |
Diastolic BP (mmHg) | 79.44 ± 6.87 | 76.90 ± 7.94 | 2.048 | 0.042* | 0.089 | 4.997 |
Pulse rate (bpm) | 83.65 ± 5.06 | 83.35 ± 5.61 | 0.337 | 0.737 | −1.465 | 2.066 |
Respiratory rate (cpm) | 19.82 ± 1.36 | 19.72 ± 1.39 | 0.441 | 0.660 | −0.352 | 0.554 |
Post C/S clinical characteristics |
|
|
|
|
| |
Systolic BP (mmHg) | 119.44 ± 8.20 | 122.17 ± 8.62 | 1.937 | 0.055 | −5.505 | 0.055 |
Diastolic BP (mmHg) | 72.86 ± 7.72 | 75.77 ± 7.19 | 2.335 | 0.021* | −5.381 | −0.446 |
Pulse rate (bpm) | 85.35 ± 6.59 | 88.89 ± 8.03 | 2.885 | 0.005* | −5.966 | −1.114 |
Respiratory rate (cpm) | 20.36 ± 1.57 | 20.38 ± 1.59 | 0.073 | 0.942 | −0.541 | 0.503 |